@blakewarner0@SarahSchaferMD@buckleydebbie Sorry I wasn't clear. - msgb doesn't remove a diagnosis. It closes MD's minds to the possibility of a diagnosis. SSA, mgsb, Schirmers, OSS, measured saliva, salivary ultrasound are ALL nonspecific & not sensitive. This is a bad way to create criteria for a disease. 🧵1/n
@blakewarner0@SarahSchaferMD@buckleydebbie 2. For most systemic medical diseases diagnosis is made by a constellation of signs & symptoms from all the systems commonly involved, not focusing on one bit (like salivary/lacrimal glands) to the exclusion of all others organs that are classic damage patterns for a disease...
@blakewarner0@SarahSchaferMD@buckleydebbie 3. Look at lupus criteria. Imagine if one had renal, cardiac & brain damage from lupus but lupus criteria only counted a facial rash, an antibody & a skin bx consistent with lupus. Nothing else counted for lupus. The patient w brain; heart & kidney damage won't b diagnosed...
@blakewarner0@SarahSchaferMD@buckleydebbie 4. That patient would be unable to get a lupus diagnosis at all! They would be unable to get treatment bc without a diagnosis insurance won't cover treatments (especially the costly one.) Is it right to deny this patient care? ...
@blakewarner0@SarahSchaferMD@buckleydebbie 5. Is it right to force that patient to wait months, years, decades or until death for them to develop a facial rash in order to get systemic monitoring & treatment?
*This is precisely what current criteria foist upon #Sjogrens patients who have an unmonitored & untreated disease
@blakewarner0@SarahSchaferMD@buckleydebbie 6. until they are "fortunate enough to have their disease attack these tiny little glands in the head. Never mind if you've had vasculitis in the brain, or CIDP (1 in 2.8 with CIDP have #Sjogrens) or interstitial lung disease or lymphoma.
@blakewarner0@SarahSchaferMD@buckleydebbie 7. It's not #Sjogrens unless & until those tiny glands get hit, regardless how many organ systems are involved & how severely they are damaged by your nameless autoimmune disease. Why this strange fascination with tiny glands when so much damage throughout the body is happening?
@blakewarner0@SarahSchaferMD@buckleydebbie 8. Try getting hydroxychloroquine or LDN or immunosuppressants or biologics without a diagnosis. Try getting systemic surveillance to catch organ damage early so can treat to increase duration & QOL. This could so easily change if this bizarre obsession w spit & tears stopped.
@blakewarner0@SarahSchaferMD@buckleydebbie 10. Compare to Sjogrens criteria (& recall #Sjogrens is ALWAYS systemic.) Notice the radical difference between these sets of criteria. Sj's have cytopenias. They'd count in lupus but not in Sj criteria. Neuro occurs in Sj's but doesn't count. Counts in lupus criteria...
@blakewarner0@SarahSchaferMD@buckleydebbie 11. Musculosk probs don't count in Sj but do in SLE. Renal counts in SLE but not in #Sjogrens. Antiphospholipid antibodies count in lupus but not in Sjogrens. I'm pretty sure the point is made. NO MD DELAYS TREATMENT for lupus until the disease hits a certain named organ.
@blakewarner0@SarahSchaferMD@buckleydebbie 12. But #Sjogrens isn't diagnosed or treated until it hits these tiny spit & tears glands. Diagnosis of a systemic AI disease ought take into account systemic aspects of the disease. It's a big picture process & a microscopic view of a salivary gland just isn't up to the job.
@blakewarner0@SarahSchaferMD@buckleydebbie 14. Current #Sjogrens classification criteria r wholly inadequate 2 represent the common spectrum of disease in Sj. The research is fixated on just a small piece of the pie chart of Sj patients. The measurements of treatment effects in research fail to assess systemic aspects.
@blakewarner0@SarahSchaferMD@buckleydebbie 15. IMO it's best to acknowledge failure early & move on to something better. Current #Sjogrens classification criteria are an abject failure for too many Sjogrens patients. Classification criteria ought NEVER be used as diagnostic criteria for obvious reasons.
@blakewarner0@SarahSchaferMD@buckleydebbie 16. It's high time #Sjogrens Diagnostic criteria be created. & for research in Sjogrens to track organ damage. And it's past time for Clinical Practice Guidelines for routine organ surveillance parameters to be published.
@blakewarner0@SarahSchaferMD@buckleydebbie 17. It's past time 4 #Sjogrens criteria 2b broadened & 2 stop fixating on salivary & lacrimal glands ALONE. No need 2 remove glands from new criteria. Just give them 1 point of many for Heme, neuro, cardiac, GI, renal, pulm points etc.
@mariaj_morenom@AbrahamAubry@SEReumatologia@SMurcianaReuma@reumalorca5@aesjogren@CatSjogren 3/n IMPORTANTLY, the authors take pains to note
1) Neuro involvement has been v underestimated 2) The disease course is more severe than previously anticipated BUT responds well to immunosuppression 3) ESSDAI issues--multiple neuro probs w same level activity only scored once so
#Dysautonomia damages ur body's automatic pilot (AP) system that controls where blood goes, how food processes/moves, temperature & glucose regulation, BP, HR,sweating etc. W AP damage there is no homeostasis, no "static" issues. Problems shift & change & r unpredictable.
#Sjogrens commonly has #AutonomicNeuropathy. Most patients have lost the ability to predict how one feels day 2 day. Hr to hr. Even minute to minute sometimes. The days of predictable baseline function are gone for many #NeuroSjogrens patients.
Loss of this baseline functionality in #NeuroSjogrens#dysautonomia erodes ability to follow thru w plans. Steals ability to work full time or at all. Wears on friends/family. Eventually many are left disabled, unemployable, poor, alone & sadly unrecognized by MD's 4 many yrs.
@gurdeep_dulay@buckleydebbie@SarahSchaferMD@SjogrensForum@MdStens History items to eval for trigeminal small fiber include change in taste (pH, loss of pain w/ hot peppers.) In irritative phase sneeze frequency & # sneezes at a time & trace nasal discharge can increase. In burned out phase sneezes & nasal secretions can stop. 1/n
@gurdeep_dulay@buckleydebbie@SarahSchaferMD@SjogrensForum@MdStens 2/n I noticed in my case most small fiber presentation has an irritative phase (IP) (positive findings of increased nerve activity) followed by a loss of function phase burned out (BO) phase (loss of small fiber sensibilities.) During IO ice cream headaches can ⬆️ 2/n
@gurdeep_dulay@buckleydebbie@SarahSchaferMD@SjogrensForum@MdStens 3/n in BO phase ice cream headaches diminish or disappear. In BO phase there is no sinus pain w/ Wasabi or strong horseradish & corneal & eye pain sensation decreases. Ophtho lidocaine drops dont sting & corneal reflex decreases (when bilateral both sides respond 3/n
Dose of interleukin 2 in study: "dose of 1 million IU or placebo subcutaneously every other day for 2 weeks, followed by a 2-week break as one treatment cycle" So, 22 doses for ~5.5K at this site: drugs.com/price-guide/pr….
Sjogrens can cause acute, subacute & chronic polyradiculopathy as seen in this report. MD's need to learn about SSEP testing when routine nerve conduction studies are normal or they might miss this diagnosis which comes in motor, sensory or both.
Sjogren's can also have a pure sensory polyradiculopathy with gait ataxia/imbalance & regular nerve conduction studies are normal. SSEP's are the only electrophysiologic tests that can localize this damage. MD's often stop at NCS & fail to obtain SSEP's. n.neurology.org/content/96/16/…
@AbrahamAubry Thread: Most DMARDS used in Sjogren's are those which have shown efficacy in related diseases and are off label uses. In part because Sjogren's gets so little research attention & systemic aspects of Sjogren's are seldom emphasized as much as sicca. 1/n
@AbrahamAubry 2/n In regards to NeuroSj use of classification criteria as selection criteria in studies excludes close to half of NeurSj patients. Even w/ limitations noted one can find smaller studies on DMARDS in Sjogrens. Here is a list of DMARDS: 1.hydroxychloroquine/chloroquine 2/n
@AbrahamAubry 3/n azathioprine, cyclosporine A, cyclophosphamide, leflunomide, methotrexate (oral and subcutaneous), and mycophenolate.